Who Buys Gemcitabine from India — 676 Importers Behind a $46.5M Market
India's gemcitabine import market is served by 676 active buyers who collectively imported $46.5M across 2,938 shipments. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with a 10.9% market share, followed by EUGIA PHARMA (MALTA) LTD, and MYLAN INSTITUTIONAL INC 2898. The top 5 buyers together control 31.3% of total import value, reflecting a moderately competitive buyer landscape.
Top Gemcitabine Importers — Ranked by Import Value
YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the leading gemcitabine importer from India, holding a 10.9% share of the $46.5M market across 2,938 shipments from 676 buyers. The top 5 buyers — YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), EUGIA PHARMA (MALTA) LTD, (MALTA), MYLAN INSTITUTIONAL INC 2898 (UNITED STATES), PHARMACIE CENTRALE DES HOPITAUX (ALGERIA), FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) — collectively control 31.3% of total import value.
Top Gemcitabine Buyers & Importers
Ranked by import value · 676 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM GEMCITABINE INJ.2G-BR-H000205209GEMCITABINE SUN PPF1200MG/120ML1S PU ITGEMCITABINE PPF 1800MG/180ML (GEMCITABIN | $5.1M | 5 | 10.9% |
| 2 | EUGIA PHARMA (MALTA) LTD,MALTA GEMCITABINE CONCENTRATED SOLUTION FOR IN | $3.4M | 5 | 7.2% |
| 3 | MYLAN INSTITUTIONAL INC 2898UNITED STATES GEMCITABINE INJECTION 2G US-F000206913GEMCITABINE INJ 38MG/ML 26.3ML 1S MYL USGEMCITABINE INJ. 1G US N+ F000206904 | $2.5M | 5 | 5.3% |
| 4 | PHARMACIE CENTRALE DES HOPITAUXALGERIA ONGECIN 1000 (GEMCITABINE FOR INJECTIONONGECIN 1000 | $2.1M | 5 | 4.5% |
| 5 | FRESENIUS KABI DEUTSCHLAND GMBHGERMANY GEMCITABINEGEMCITABINE FRESENIUSINJ.1GGEMCITABINE KABI INJ. 1000MG/26.3ML VIALGEMITA USP INJ. 1.4GM/VI | $1.6M | 5 | 3.4% |
| 6 | XXIZEXXSERXXCE XXMPAXX BVCZECH REPUBLIC GEMCITABINE INJECTION 2G US-F000206913GEMCITABINE INJ 38MG/ML 26.3ML 1S MYL USGEMCITABINE INJ. 1G US N+ F000206904 | $1.4M | 5 | 3.0% |
| 7 | MYLAN INSTITUTIONAL INCUNITED STATES GEMCITABINE INJECTION 2G US-F000206913GEMCITABINE INJ 38MG/ML 26.3ML 1S MYL USGEMCITABINE INJ. 1G US N+ F000206904 | $1.2M | 5 | 2.7% |
| 8 | OOO JODAS EXPOIMRUSSIA GEMCITABINE LYOPHILIZATE FOR PREPARATION | $1.2M | 5 | 2.6% |
| 9 | PFIZER SERVICE COMPANY BVHONG KONG GEMCITABINE INJECTION 2G US-F000206913GEMCITABINE INJ 38MG/ML 26.3ML 1S MYL USGEMCITABINE INJ. 1G US N+ F000206904 | $1.1M | 5 | 2.4% |
| 10 | EVERSANA LIFE SCIENCES SERVICES,LLCUNITED STATES GEMCITABINE INJECTION 2G US-F000206913GEMCITABINE INJ 38MG/ML 26.3ML 1S MYL USGEMCITABINE INJ. 1G US N+ F000206904 | $946.8K | 5 | 2.0% |
| 11 | AMERISOURCE HEALTH SERVICESUNITED STATES GEMCITABINE INJECTION 2G US-F000206913GEMCITABINE INJ 38MG/ML 26.3ML 1S MYL USGEMCITABINE INJ. 1G US N+ F000206904 | $920.4K | 5 | 2.0% |
| 12 | FARMA VISION IMP E EXP DE MEDICAMENBRAZIL | $841.5K | 5 | 1.8% |
| 13 | SPA IMGSA GROUPE INSDUSTRIESALGERIA ONGECIN 1000 (GEMCITABINE FOR INJECTIONONGECIN 1000 | $748.4K | 5 | 1.6% |
| 14 | FRESENIUS KABI (THAILAND) LTD.,THAILAND GEMCITABINEGEMCITABINE FRESENIUSINJ.1GGEMCITABINE KABI INJ. 1000MG/26.3ML VIALGEMITA USP INJ. 1.4GM/VI | $704.8K | 5 | 1.5% |
| 15 | OOOJODAS EXPOIMRUSSIA GEMCITABINE LYOPHILIZATE FOR PREPARATION | $677.7K | 5 | 1.5% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Gemcitabine — and from which countries?
Flow of Gemcitabine exports from India: each country's share and the named importers behind the numbers
Gemcitabine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $7.8M through 47 shipments. This represents a market share of 16.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• MYLAN INSTITUTIONAL INC 2898 - $2.5M (31.5% of country's total business)
• MYLAN INSTITUTIONAL INC - $1.2M (16.0% of country's total business)
• EVERSANA LIFE SCIENCES SERVICES,LLC - $946.8K (12.1% of country's total business)
• AMERISOURCE HEALTH SERVICES - $920.4K (11.8% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $166.1K, indicating premium pricing strategy compared to the market average of $15.8K.
United States is a key market for Gemcitabine imports, representing 16.8% of total trade value.
2Belgium
Belgium emerges as the second largest importing country, achieving a total trade value of $5.9M through 116 shipments. This represents a market share of 12.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $5.1M (85.9% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $50.9K, indicating premium pricing strategy compared to the market average of $15.8K.
Belgium is a key market for Gemcitabine imports, representing 12.7% of total trade value.
3Malta
Malta emerges as the third largest importing country, achieving a total trade value of $5.4M through 142 shipments. This represents a market share of 11.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malta has a diverse importer base, with their top importers including:
• EUGIA PHARMA (MALTA) LTD, - $3.4M (62.2% of country's total business)
• APL SWIFT SERVICES (MALTA) LTD., - $631.4K (11.7% of country's total business)
Key Insight: Malta demonstrates strong market positioning with an average shipment value of $38.2K, indicating premium pricing strategy compared to the market average of $15.8K.
Malta is a key market for Gemcitabine imports, representing 11.6% of total trade value.
4Algeria
Algeria emerges as the fourth largest importing country, achieving a total trade value of $3.5M through 87 shipments. This represents a market share of 7.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Algeria has a diverse importer base, with their top importers including:
• PHARMACIE CENTRALE DES HOPITAUX - $2.1M (59.5% of country's total business)
• SPA IMGSA GROUPE INSDUSTRIES - $748.4K (21.2% of country's total business)
Key Insight: Algeria demonstrates strong market positioning with an average shipment value of $40.6K, indicating premium pricing strategy compared to the market average of $15.8K.
Algeria is a key market for Gemcitabine imports, representing 7.6% of total trade value.
5Russia
Russia emerges as the fifth largest importing country, achieving a total trade value of $2.9M through 23 shipments. This represents a market share of 6.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• OOO JODAS EXPOIM - $1.2M (40.9% of country's total business)
• OOOJODAS EXPOIM - $677.7K (23.3% of country's total business)
• OOO"JODAS EXPOIM" - $481.1K (16.5% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $126.6K, indicating premium pricing strategy compared to the market average of $15.8K.
Russia is a key market for Gemcitabine imports, representing 6.3% of total trade value.
Buyer Segment Analysis
TransData Nexus Gemcitabine buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Gemcitabine exports from India amounted to $46.5 million across 2,938 shipments, involving 248 exporters and 676 buyers spanning 125 importing countries. The repeat buyer rate stands at 60.4%, suggesting a stable demand base.
Buyer Segments:
1. Distributors: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $5.07M) and EUGIA PHARMA (MALTA) LTD (Malta, $3.37M) function as intermediaries, procuring large volumes to supply regional markets. Their purchasing patterns are characterized by bulk orders aligned with market demand forecasts.
2. Hospital Groups: Organizations such as PHARMACIE CENTRALE DES HOPITAUX (Algeria, $2.10M) represent centralized procurement bodies for hospital networks, focusing on consistent supply to meet patient needs. Their orders are typically regular and substantial, ensuring uninterrupted treatment availability.
3. Government Procurement Agencies: Entities like FRESENIUS KABI DEUTSCHLAND GMBH (Germany, $1.58M) may engage in tender-based purchasing for public healthcare systems, emphasizing cost-effectiveness and quality assurance. Their procurement processes are often periodic, following structured tender cycles.
4. Re-exporters: Companies such as XXIZEXXSERXXCE XXMPAXX BV (Czech Republic, $1.38M) may act as re-exporters, importing Gemcitabine for redistribution to neighboring regions, leveraging logistical advantages. Their buying behavior is influenced by regional demand fluctuations and trade agreements.
5. Contract Manufacturers: Firms like MYLAN INSTITUTIONAL INC (United States, $2.46M) and OOO JODAS EXPOIM (Russia, $1.19M) may procure Gemcitabine as active pharmaceutical ingredients (APIs) for formulation into finished products. Their orders are typically aligned with production schedules and regulatory approvals.
Country-Specific Import Regulations
TransData Nexus Gemcitabine buyer market intelligence
1Country-Specific Import Regulations
United States:
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Gemcitabine is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.
3. Estimated Timeline: The FDA review process for NDAs typically takes 10 months, while ANDAs may take 8-10 months.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are generally duty-free in the United States.
Belgium:
1. Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
2. Import Registration Process: Importers must obtain a marketing authorization from FAMHP, which includes submitting a dossier demonstrating the product's quality, safety, and efficacy.
3. Estimated Timeline: The evaluation process can take up to 210 days, excluding clock stops for additional information requests.
4. Import Tariff/Duty: As an EU member state, Belgium applies a 0% tariff on pharmaceutical products under HS Code 30049049.
Malta:
1. Regulatory Authority: Malta Medicines Authority (MMA).
2. Import Registration Process: Importers must apply for a marketing authorization, providing comprehensive data on the product.
3. Estimated Timeline: The process typically takes 210 days, in line with EU directives.
4. Import Tariff/Duty: Malta, as an EU member, imposes a 0% tariff on pharmaceutical imports under HS Code 30049049.
Algeria:
1. Regulatory Authority: Agence Nationale des Produits Pharmaceutiques (ANPP).
2. Import Registration Process: Importers must obtain a registration certificate from ANPP, involving the submission of a technical dossier and compliance with local regulations.
3. Estimated Timeline: The registration process can take approximately 12 months, depending on dossier completeness and regulatory workload.
4. Import Tariff/Duty: Algeria imposes a 5% import duty on pharmaceutical products under HS Code 30049049.
Russia:
1. Regulatory Authority: Ministry of Health of the Russian Federation.
2. Import Registration Process: Importers must obtain a registration certificate, which includes submitting a dossier and undergoing local clinical trials if required.
3. Estimated Timeline: The registration process typically takes 12-18 months.
4. Import Tariff/Duty: Russia applies a 0% import duty on pharmaceutical products under HS Code 30049049.
Demand Drivers & Market Opportunity
TransData Nexus Gemcitabine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Gemcitabine is primarily driven by its efficacy in treating various cancers, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer. The global incidence of these cancers has been rising, necessitating increased access to effective chemotherapy agents.
Government healthcare programs and the expansion of universal health coverage have significantly influenced Gemcitabine procurement. Many countries include Gemcitabine in their national essential medicines lists, aligning with the World Health Organization's Essential Medicines List, which emphasizes the importance of accessible cancer treatments. Tender-based purchasing is a common procurement strategy, ensuring cost-effective and equitable access to essential medicines. Our data, indicating 676 buyers across 125 countries, reflects the widespread adoption of such procurement practices.
Common Questions — Gemcitabine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest gemcitabine buyer importing from India?
Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $5.1M in imports and a 10.9% market share — the highest of any single gemcitabine importer. EUGIA PHARMA (MALTA) LTD, (MALTA) and MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) are the next largest buyers.
QHow many companies buy gemcitabine from India?
There are 676 active gemcitabine buyers importing from India, with a combined market of $46.5M across 2,938 shipments to 125 countries. The top 5 buyers hold 31.3% of total import value, while the remaining 671 buyers handle the other 68.7%.
QWhich countries import the most gemcitabine from India?
The top importing countries for gemcitabine from India are United States (16.8%), Belgium (12.7%), Malta (11.6%), Algeria (7.6%), Russia (6.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of gemcitabine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for gemcitabine from India?
The average import transaction value for gemcitabine from India is $15.8K, with an average unit price of $10.70 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Gemcitabine buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Gemcitabine exports from India amounted to $46.5 million across 2,938 shipments, involving 248 exporters and 676 buyers spanning 125 importing countries. The repeat buyer rate stands at 60.4%, suggesting a stable demand base.
Buyer Segments:
1. Distributors: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $5.07M) and EUGIA PHARMA (MALTA) LTD (Malta, $3.37M) function as intermediaries, procuring large volumes to supply regional markets. Their purchasing patterns are characterized by bulk orders aligned with market demand forecasts.
2. Hospital Groups: Organizations such as PHARMACIE CENTRALE DES HOPITAUX (Algeria, $2.10M) represent centralized procurement bodies for hospital networks, focusing on consistent supply to meet patient needs. Their orders are typically regular and substantial, ensuring uninterrupted treatment availability.
3. Government Procurement Agencies: Entities like FRESENIUS KABI DEUTSCHLAND GMBH (Germany, $1.58M) may engage in tender-based purchasing for public healthcare systems, emphasizing cost-effectiveness and quality assurance. Their procurement processes are often periodic, following structured tender cycles.
4. Re-exporters: Companies such as XXIZEXXSERXXCE XXMPAXX BV (Czech Republic, $1.38M) may act as re-exporters, importing Gemcitabine for redistribution to neighboring regions, leveraging logistical advantages. Their buying behavior is influenced by regional demand fluctuations and trade agreements.
5. Contract Manufacturers: Firms like MYLAN INSTITUTIONAL INC (United States, $2.46M) and OOO JODAS EXPOIM (Russia, $1.19M) may procure Gemcitabine as active pharmaceutical ingredients (APIs) for formulation into finished products. Their orders are typically aligned with production schedules and regulatory approvals.
Country-Specific Import Regulations
TransData Nexus Gemcitabine buyer market intelligence
1Country-Specific Import Regulations
United States:
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Gemcitabine is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.
3. Estimated Timeline: The FDA review process for NDAs typically takes 10 months, while ANDAs may take 8-10 months.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are generally duty-free in the United States.
Belgium:
1. Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
2. Import Registration Process: Importers must obtain a marketing authorization from FAMHP, which includes submitting a dossier demonstrating the product's quality, safety, and efficacy.
3. Estimated Timeline: The evaluation process can take up to 210 days, excluding clock stops for additional information requests.
4. Import Tariff/Duty: As an EU member state, Belgium applies a 0% tariff on pharmaceutical products under HS Code 30049049.
Malta:
1. Regulatory Authority: Malta Medicines Authority (MMA).
2. Import Registration Process: Importers must apply for a marketing authorization, providing comprehensive data on the product.
3. Estimated Timeline: The process typically takes 210 days, in line with EU directives.
4. Import Tariff/Duty: Malta, as an EU member, imposes a 0% tariff on pharmaceutical imports under HS Code 30049049.
Algeria:
1. Regulatory Authority: Agence Nationale des Produits Pharmaceutiques (ANPP).
2. Import Registration Process: Importers must obtain a registration certificate from ANPP, involving the submission of a technical dossier and compliance with local regulations.
3. Estimated Timeline: The registration process can take approximately 12 months, depending on dossier completeness and regulatory workload.
4. Import Tariff/Duty: Algeria imposes a 5% import duty on pharmaceutical products under HS Code 30049049.
Russia:
1. Regulatory Authority: Ministry of Health of the Russian Federation.
2. Import Registration Process: Importers must obtain a registration certificate, which includes submitting a dossier and undergoing local clinical trials if required.
3. Estimated Timeline: The registration process typically takes 12-18 months.
4. Import Tariff/Duty: Russia applies a 0% import duty on pharmaceutical products under HS Code 30049049.
Demand Drivers & Market Opportunity
TransData Nexus Gemcitabine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Gemcitabine is primarily driven by its efficacy in treating various cancers, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer. The global incidence of these cancers has been rising, necessitating increased access to effective chemotherapy agents.
Government healthcare programs and the expansion of universal health coverage have significantly influenced Gemcitabine procurement. Many countries include Gemcitabine in their national essential medicines lists, aligning with the World Health Organization's Essential Medicines List, which emphasizes the importance of accessible cancer treatments. Tender-based purchasing is a common procurement strategy, ensuring cost-effective and equitable access to essential medicines. Our data, indicating 676 buyers across 125 countries, reflects the widespread adoption of such procurement practices.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 676 global importers of Gemcitabine identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 2,938 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 125 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,938 Verified Shipments
676 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists